General Information of Drug (ID: DMPMVRL)

Drug Name
Daridorexant Drug Info
Indication
Disease Entry ICD 11 Status REF
Insomnia 7A00-7A0Z Approved [1]
Cross-matching ID
PubChem CID
91801202
TTD Drug ID
DMPMVRL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug(s) Targeting Orexin receptor (HCRTR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
1,2-diamino cyclopentane-based derivative 28 DMUTF17 N. A. N. A. Patented [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Orexin receptor (HCRTR) TT9BPT3 NOUNIPROTAC Antagonist [1]

References

1 FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 214985.
2 Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934).Expert Opin Ther Pat. 2016;26(3):409-15.